Resource Center Access industry insights and real-world results. Meeting Key Opinion Leaders Where They AreMedical Affairs teams influence every stage of the medical product life cycle – identifying unmet healthcare needs, highlighting evidence gaps, and educating scientific and medical experts on new drugs… Continue reading → Read the article Read the latest perspectives from our team of subject matter experts. Go to BlogResource Types:Case Studies Customer Stories Executive Briefs Infographics Perspectives Podcasts Resource Guides Videos Webinars White Papers Resource Topics:Artificial Intelligence Commercialization Diversity & Inclusion Drug Development Global Missions KOL Engagement Provider Data Resource Industries:Commercialization Global Health Network Payors Pharmaceutical & Biotechnology Provider Data Case StudiesGRM Turns to H1 Connect to Deploy for Ukraine Trauma Surgery Training Case StudiesAccelerating New Drug Indication Launch Through Strategic Thought Leader Engagement Case StudiesHCP Education for Brand Activation in Endocrinology Case StudiesMedical Affairs Engagement Strategy for IBD/GI Case StudiesMedical Affairs Digital Engagement Strategy for Cardiology Case StudiesEquitable Clinical Trial Access for Women, Minorities Among Cardiovascular Disease in the U.S. Case StudiesU.S. Pharma Marketing Team Partners with H1 to Expand Cardiorenal KOL Mapping and Engagement Case StudiesA Case Study on H1 Visual MSL Territory Alignment with Claims and Scholarly Data Case StudiesTop 10 Global Pharma Seeks Treatment Leaders to Advance Diversity Strategies for a Phase II Cardiology Trial Case StudiesCase Study: The Role of Enterprise Data Intelligence for Pharma Case StudiesMaximizing Clinical Trial Success Case StudiesKOL Identification to Support Brand Launch Increases Engagement at a Congress Case StudiesEmpowering Clinical Trial Diversity Case StudiesTrifecta: Finding Value in the Spectrum of KOLs Today Case StudiesTop 10 Pharma Finds Key HCPs for Eye-Related Diseases Case StudiesAccessing Diverse Patient Populations through Clinical Trial Diversity and Inclusion Data Case StudiesA Global Medical Affairs Team Finds Opportunity with H1 Case StudiesA U.S. Pharma Team Enhances KOL Lists by 200% Case StudiesDiversity & Inclusion Insights for Equitable Research Case StudiesComposable Intelligence for Key Opinion Leader Strategy and Engagement